408 related articles for article (PubMed ID: 29211044)
21. Inflammatory cytokines and NT-proCNP in Parkinson's disease patients.
Koziorowski D; Tomasiuk R; Szlufik S; Friedman A
Cytokine; 2012 Dec; 60(3):762-6. PubMed ID: 22910321
[TBL] [Abstract][Full Text] [Related]
22. miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.
Mushtaq G; Greig NH; Anwar F; Zamzami MA; Choudhry H; Shaik MM; Tamargo IA; Kamal MA
Med Chem; 2016; 12(3):217-25. PubMed ID: 26527155
[TBL] [Abstract][Full Text] [Related]
23. [Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy].
Litvinenko IV; Krasakov IV; Bisaga GN; Skulyabin DI; Poltavsky ID
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6. Vyp. 2):3-10. PubMed ID: 28980606
[TBL] [Abstract][Full Text] [Related]
24. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.
Andican G; Konukoglu D; Bozluolcay M; Bayülkem K; Firtiına S; Burcak G
Acta Neurol Belg; 2012 Jun; 112(2):155-9. PubMed ID: 22426659
[TBL] [Abstract][Full Text] [Related]
25. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
Gelders G; Baekelandt V; Van der Perren A
J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
[TBL] [Abstract][Full Text] [Related]
26. Neurosteroids as regulators of neuroinflammation.
Yilmaz C; Karali K; Fodelianaki G; Gravanis A; Chavakis T; Charalampopoulos I; Alexaki VI
Front Neuroendocrinol; 2019 Oct; 55():100788. PubMed ID: 31513776
[TBL] [Abstract][Full Text] [Related]
27. CSF Cytokines in Aging, Multiple Sclerosis, and Dementia.
Hu WT; Howell JC; Ozturk T; Gangishetti U; Kollhoff AL; Hatcher-Martin JM; Anderson AM; Tyor WR
Front Immunol; 2019; 10():480. PubMed ID: 30930904
[TBL] [Abstract][Full Text] [Related]
28. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM
PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969
[TBL] [Abstract][Full Text] [Related]
29. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).
Ringheim GE; Conant K
J Neuroimmunol; 2004 Feb; 147(1-2):43-9. PubMed ID: 14741426
[TBL] [Abstract][Full Text] [Related]
30. A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?
Perga S; Martire S; Montarolo F; Navone ND; Calvo A; Fuda G; Marchet A; Leotta D; Chiò A; Bertolotto A
Neurotox Res; 2017 Jul; 32(1):1-7. PubMed ID: 28337659
[TBL] [Abstract][Full Text] [Related]
31. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
[TBL] [Abstract][Full Text] [Related]
32. Association between serum haptoglobin and the pathogenesis of Alzheimer's disease.
Song IU; Kim YD; Chung SW; Cho HJ
Intern Med; 2015; 54(5):453-7. PubMed ID: 25758069
[TBL] [Abstract][Full Text] [Related]
33. Can we prevent Parkinson's and Alzheimer's disease?
Kedar NP
J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
[TBL] [Abstract][Full Text] [Related]
34. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A
Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650
[TBL] [Abstract][Full Text] [Related]
35. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
Kustrimovic N; Marino F; Cosentino M
Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
[TBL] [Abstract][Full Text] [Related]
36. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
Dzamko N; Rowe DB; Halliday GM
Mov Disord; 2016 Jun; 31(6):889-97. PubMed ID: 26917005
[TBL] [Abstract][Full Text] [Related]
37. NeurimmiRs: microRNAs in the neuroimmune interface.
Soreq H; Wolf Y
Trends Mol Med; 2011 Oct; 17(10):548-55. PubMed ID: 21813326
[TBL] [Abstract][Full Text] [Related]
38. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy for Parkinson's disease.
Schwab AD; Thurston MJ; Machhi J; Olson KE; Namminga KL; Gendelman HE; Mosley RL
Neurobiol Dis; 2020 Apr; 137():104760. PubMed ID: 31978602
[TBL] [Abstract][Full Text] [Related]
40. The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases.
Huang B; Zhenxin Y; Chen S; Tan Z; Zong Z; Zhang H; Xiong X
Oxid Med Cell Longev; 2022; 2022():1315248. PubMed ID: 36211819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
